MORGAN STANLEY - PLURISTEM THERAPEUTICS INC ownership

PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R300. A total of 39 filers reported holding PLURISTEM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of PLURISTEM THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$19,000
-38.7%
15,285
+1.1%
0.00%
Q1 2022$31,000
+3.3%
15,125
-27.3%
0.00%
Q4 2021$30,000
-88.0%
20,805
-78.1%
0.00%
Q3 2021$251,000
-17.4%
95,081
+23.5%
0.00%
Q2 2021$304,000
+6.7%
77,014
+29.1%
0.00%
Q1 2021$285,000
+171.4%
59,646
+301.2%
0.00%
Q4 2020$105,000
-7.1%
14,867
+38.2%
0.00%
Q3 2020$113,000
+9.7%
10,754
-8.3%
0.00%
Q2 2020$103,000
+586.7%
11,725
+173.7%
0.00%
Q1 2020$15,000
+200.0%
4,284
+285.6%
0.00%
Q4 2019$5,0000.0%1,111
-29.7%
0.00%
Q3 2019$5,0001,5800.00%
Other shareholders
PLURISTEM THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
NIA IMPACT ADVISORS, LLC 732,135$1,940,0000.83%
Green Alpha Advisors, LLC 61,759$164,0000.11%
Values First Advisors, Inc. 49,179$130,0000.08%
GSA CAPITAL PARTNERS LLP 257,684$683,0000.07%
SHELTON CAPITAL MANAGEMENT 240,000$636,0000.02%
Walleye Capital LLC 154,997$411,0000.01%
PDT Partners, LLC 59,400$157,0000.01%
Archford Capital Strategies, LLC 13,091$35,0000.01%
Susquehanna International Group Ltd. 13,164$35,0000.01%
MEITAV INVESTMENT HOUSE LTD 167,593$444,0000.01%
View complete list of PLURISTEM THERAPEUTICS INC shareholders